Data Foundry

Drug recalls 2026

Accucaine — Class II drug recall D-0658-2026

Ongoing recall by Asclemed USA Inc., reported 2026-07-08, distributed nationwide. Lack of Assurance of Sterility

Recall numberD-0658-2026
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmAsclemed USA Inc., Torrance, CA, United States
Recall initiated2026-06-08
Classified2026-07-02
Reported by FDA2026-07-08
DistributedNationwide (US)
Reason classessterility
NDC76420-0715, 76420-0715-01
Lot numbers010626X3, 022525X4, 030426X2, 033125X1, 033125X2, 041326X4, 041426X2, 041725X3, 041726X1, 051826X2, 061225X1, 072225X3, 080525X6, 080525X7, 080525X8, 091225X1, 100225X2, 100625X1, 121924X2, 122225X4, AE3102, AE5052
Expiration dates2026-11-30, 2028-04-30

Product

Accucaine, Kit contains: Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-715-01.

Reason for recall

Lack of Assurance of Sterility

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0658-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.